-
Research
-
- Funding & Notices
- News & Media
- About Translation
-
- About NCATS
-
NCATS Programs & Initiatives
- 3-D Tissue Bioprinting Program
- A Specialized Platform for Innovative Research Exploration (ASPIRE)
- Assay Development and Screening Technology (ADST)
- Biomedical Data Translator
- Bridging Interventional Development Gaps (BrIDGs)
- Chemistry Technology
- Discovering New Therapeutic Uses for Existing Molecules
- Genetic and Rare Diseases Information Center (GARD)
- Matrix Combination Screening
- Early Translation Branch (ETB)
- A Specialized Platform for Innovative Research Exploration (ASPIRE)
- NIH Common Fund Programs
- Rare Diseases Registry Program (RaDaR)
- Tissue Chip for Drug Screening
- Toxicology in the 21st Century (Tox21)
- Functional Genomics Lab
- Therapeutics for Rare and Neglected Diseases (TRND)
- About NCATS
- Home
- News & Media
- News & Events
- Releases & Announcements
Releases & Announcements
In the Spotlight
A Promising Step in the Fight Against Lethal Childhood Brain Cancers
NCATS, NIH ∙ 11/20/2019 ∙ Matrix Screening
Researchers have identified a promising two-drug combination to treat deadly childhood brain cancers known as diffuse midline gliomas. The drugs work together to kill cancer cells and counter the effects of a genetic mutation that causes the diseases.
November 2019
-
A Promising Step in the Fight Against Lethal Childhood Brain Cancers
NCATS, NIH ∙ 11/20/2019 ∙ Matrix Screening
- Funding & Notices
-